https://es.marketscreener.com/cotizacion/accion/NOTABLE-LABS-LTD-17053959/noticia/Notable-Labs-Ltd-Avanza-el-Programa-de-Fase-2-de-Volasertib-Utilizando-la-Plataforma-Propia-de-Med-46018236/?utm_source=telegram&utm_medium=social&utm_campaign=share